Oral Clofarabine Study in Patients With Myelodysplastic Syndrome

NCT00299156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Chronic Myelomonocytic Leukemia

Interventions

DRUG: Clofarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]